SI1343529T1 - NSAID formulacije, ki vsebujejo lecitinska olja, za zaščito gastrointestinalnega trakta in zagotovitev povečanja terapevtske aktivnosti - Google Patents
NSAID formulacije, ki vsebujejo lecitinska olja, za zaščito gastrointestinalnega trakta in zagotovitev povečanja terapevtske aktivnostiInfo
- Publication number
- SI1343529T1 SI1343529T1 SI200130899T SI200130899T SI1343529T1 SI 1343529 T1 SI1343529 T1 SI 1343529T1 SI 200130899 T SI200130899 T SI 200130899T SI 200130899 T SI200130899 T SI 200130899T SI 1343529 T1 SI1343529 T1 SI 1343529T1
- Authority
- SI
- Slovenia
- Prior art keywords
- therapeutic activity
- enhanced therapeutic
- protecting
- gastrointestinal tract
- providing enhanced
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25671100P | 2000-12-19 | 2000-12-19 | |
PCT/US2001/051605 WO2002085414A2 (en) | 2000-12-19 | 2001-12-19 | Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
EP01273758A EP1343529B1 (en) | 2000-12-19 | 2001-12-19 | Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1343529T1 true SI1343529T1 (sl) | 2009-04-30 |
Family
ID=22973287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200130899T SI1343529T1 (sl) | 2000-12-19 | 2001-12-19 | NSAID formulacije, ki vsebujejo lecitinska olja, za zaščito gastrointestinalnega trakta in zagotovitev povečanja terapevtske aktivnosti |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1343529B1 (sl) |
JP (2) | JP4958381B2 (sl) |
KR (1) | KR100884493B1 (sl) |
CN (2) | CN102258457B (sl) |
AT (1) | ATE414542T1 (sl) |
AU (1) | AU2001297778B2 (sl) |
BR (1) | BR0116380A (sl) |
CA (1) | CA2431606C (sl) |
CY (1) | CY1110474T1 (sl) |
DE (1) | DE60136647D1 (sl) |
DK (1) | DK1343529T3 (sl) |
ES (1) | ES2317873T3 (sl) |
HK (1) | HK1161107A1 (sl) |
IL (2) | IL156361A0 (sl) |
MX (1) | MXPA03005550A (sl) |
PT (1) | PT1343529E (sl) |
SI (1) | SI1343529T1 (sl) |
WO (1) | WO2002085414A2 (sl) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060054405A (ko) * | 2003-07-31 | 2006-05-22 | 더 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 | 암, 암의 발병 또는 암 증상의 치료, 예방 및/또는 개선용조성물 및 방법 |
US20050176809A1 (en) * | 2004-02-05 | 2005-08-11 | Rodlen Laboratories, Inc. | Method and compositions for treatment of painful disorders |
WO2005084683A1 (fr) * | 2004-03-03 | 2005-09-15 | MARTINS, José, Araujo | Composition a base de lecithine vegetale, ex. de soja, vitamines du complexe b et d'acide acetylsalicylique, et son utilisation pour la fabrication d'un medicament pour le traitement des maladies neuro-degeneratives |
CA2584505A1 (en) | 2004-10-12 | 2006-04-27 | Lenard M. Lichtenberger | Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same |
GB0517673D0 (en) * | 2005-08-31 | 2005-10-05 | Astrazeneca Ab | Formulation |
CN101346128B (zh) * | 2005-10-25 | 2013-10-02 | 雅培制药有限公司 | 包含低水溶解度药物的配方及其使用方法 |
KR20090034385A (ko) | 2006-07-19 | 2009-04-07 | 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 | 염증성 장질환을 치료하기 위한 5-아미노살리실산 함유 약제 및 인지질의 제제 |
US20110008396A1 (en) * | 2007-09-20 | 2011-01-13 | Rutgers, The Sate University Of New Jersey | Compositions and methods for treating cardiovascular conditions |
GB2477590A (en) * | 2010-02-05 | 2011-08-10 | Biocopea Ltd | A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier |
KR101957177B1 (ko) * | 2010-10-22 | 2019-03-12 | 닥터 레디스 래보러토리즈 에스에이 | 상처를 치료하기 위한 저장 안정한 점성 인지질 데포의 용도 |
US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
US9737500B2 (en) | 2010-10-29 | 2017-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
US8895536B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating chronic inflammation and inflammatory diseases |
US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
MX346224B (es) * | 2011-02-04 | 2017-03-10 | Biocopea Ltd | Composiciones y metodos para el tratamiento de inflamacion cronica y enfermedades inflamatorias. |
WO2013022410A2 (en) | 2011-08-08 | 2013-02-14 | Mahmut Bilgic | Production method for effervescent formulations comprising dexketoprofen |
KR102162901B1 (ko) * | 2011-09-29 | 2020-10-08 | 피엘엑스 옵코 인코포레이티드 | 위장관을 따라 약물을 표적화 방출하기 위한 pH 감응성 담체, 그로부터의 조성물, 및 이들의 제조 및 사용 방법 |
EP2999487A1 (en) * | 2013-05-23 | 2016-03-30 | Neurosn, Inc. | Diagnosing and treating alzheimer's disease using annexins with labeled with a radionuclide |
RU2016136430A (ru) * | 2014-02-11 | 2018-03-15 | Др. Редди'С Лабораторис Лтд. | Парентеральные композиции целекоксиба |
CN103908454B (zh) * | 2014-04-17 | 2016-08-24 | 兆科药业(广州)有限公司 | 一种药物组合物及其制备方法和应用 |
WO2016094617A1 (en) * | 2014-12-11 | 2016-06-16 | Phosphorex, Inc. | Aqueous topical drug formulation with controlled release and increased stability |
CN104739843A (zh) * | 2015-04-15 | 2015-07-01 | 郭志标 | 一种用于治疗口腔溃疡的药物组合物 |
AU2019231699B2 (en) * | 2018-03-07 | 2023-03-09 | Andrew Xian Chen | Aqueous formulations for insoluble drugs |
CN108542909B (zh) * | 2018-03-30 | 2020-07-07 | 浙江海昶生物医药技术有限公司 | 一种阿司匹林磷脂固化组合物、其制备方法及药物制剂 |
JP7229012B2 (ja) | 2018-12-25 | 2023-02-27 | 小林製薬株式会社 | 内服用医薬組成物 |
AU2021244695A1 (en) | 2020-03-26 | 2022-11-10 | Plx Opco Inc. | Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60208910A (ja) * | 1984-03-31 | 1985-10-21 | Green Cross Corp:The | 水難溶性薬物・リン脂質複合体の製造方法 |
US5154930A (en) * | 1987-03-05 | 1992-10-13 | The Liposome Company, Inc. | Pharmacological agent-lipid solution preparation |
US5091188A (en) * | 1990-04-26 | 1992-02-25 | Haynes Duncan H | Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
AU661755B2 (en) * | 1992-02-12 | 1995-08-03 | Janssen - Cilag - S.p.a. | Liposomal piroxicam formulations |
JP3176425B2 (ja) * | 1992-04-03 | 2001-06-18 | 三洋電機株式会社 | 空気調和機の電流検出方法および電流検出装置 |
ATE218872T1 (de) * | 1995-01-27 | 2002-06-15 | Univ Texas | Verfahren zur erhöhung der therapeutischen wirkung von nsaids und dazu verwendbare zwitterionische phospholipidhaltige zusammensetungen |
US5955451A (en) * | 1995-05-12 | 1999-09-21 | The University Of Texas System Board Of Regents | Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein |
-
2001
- 2001-12-19 JP JP2002582987A patent/JP4958381B2/ja not_active Expired - Fee Related
- 2001-12-19 KR KR1020037008167A patent/KR100884493B1/ko active IP Right Grant
- 2001-12-19 MX MXPA03005550A patent/MXPA03005550A/es active IP Right Grant
- 2001-12-19 CN CN201110165238.6A patent/CN102258457B/zh not_active Expired - Lifetime
- 2001-12-19 DK DK01273758T patent/DK1343529T3/da active
- 2001-12-19 DE DE60136647T patent/DE60136647D1/de not_active Expired - Lifetime
- 2001-12-19 PT PT01273758T patent/PT1343529E/pt unknown
- 2001-12-19 AU AU2001297778A patent/AU2001297778B2/en not_active Expired
- 2001-12-19 IL IL15636101A patent/IL156361A0/xx unknown
- 2001-12-19 CA CA2431606A patent/CA2431606C/en not_active Expired - Lifetime
- 2001-12-19 CN CNA018223834A patent/CN1543358A/zh active Pending
- 2001-12-19 AT AT01273758T patent/ATE414542T1/de active
- 2001-12-19 EP EP01273758A patent/EP1343529B1/en not_active Expired - Lifetime
- 2001-12-19 ES ES01273758T patent/ES2317873T3/es not_active Expired - Lifetime
- 2001-12-19 SI SI200130899T patent/SI1343529T1/sl unknown
- 2001-12-19 WO PCT/US2001/051605 patent/WO2002085414A2/en active IP Right Grant
- 2001-12-19 BR BR0116380-9A patent/BR0116380A/pt not_active Application Discontinuation
-
2003
- 2003-06-09 IL IL156361A patent/IL156361A/en active IP Right Grant
-
2009
- 2009-02-17 CY CY20091100168T patent/CY1110474T1/el unknown
- 2009-11-06 JP JP2009255329A patent/JP2010031044A/ja not_active Withdrawn
-
2012
- 2012-02-21 HK HK12101682.7A patent/HK1161107A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MXPA03005550A (es) | 2004-05-14 |
CN102258457A (zh) | 2011-11-30 |
BR0116380A (pt) | 2005-04-05 |
DK1343529T3 (da) | 2009-03-16 |
AU2001297778C1 (en) | 2002-11-05 |
CN1543358A (zh) | 2004-11-03 |
KR20030072565A (ko) | 2003-09-15 |
JP2010031044A (ja) | 2010-02-12 |
CA2431606C (en) | 2011-07-19 |
EP1343529B1 (en) | 2008-11-19 |
PT1343529E (pt) | 2009-02-27 |
EP1343529A2 (en) | 2003-09-17 |
WO2002085414A2 (en) | 2002-10-31 |
KR100884493B1 (ko) | 2009-02-18 |
IL156361A (en) | 2011-04-28 |
ES2317873T3 (es) | 2009-05-01 |
IL156361A0 (en) | 2004-01-04 |
JP4958381B2 (ja) | 2012-06-20 |
CN102258457B (zh) | 2015-07-01 |
JP2005506303A (ja) | 2005-03-03 |
CA2431606A1 (en) | 2002-10-31 |
HK1161107A1 (en) | 2012-08-24 |
WO2002085414A3 (en) | 2003-05-08 |
DE60136647D1 (de) | 2009-01-02 |
AU2001297778B2 (en) | 2007-05-31 |
CY1110474T1 (el) | 2015-04-29 |
ATE414542T1 (de) | 2008-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03005550A (es) | Formulaciones de nsaid que comprenden aceites de lecitina para proteger el tracto gastrointestinal y proporcionar actividad terapeutica mejorada. | |
ES2605405T3 (es) | Composiciones que contienen agentes antiacné y su uso | |
KR102073258B1 (ko) | 통증 완화용 국소 조성물, 제조방법 및 용도 | |
US10159693B2 (en) | Strontium-containing complexes for treatment of pain, pruritis and inflammation | |
KR20110017451A (ko) | 소염 진통 외용제 | |
JP7322094B2 (ja) | 疼痛、掻痒症および炎症のためのストロンチウムをベースとする組成物および製剤 | |
US9480704B2 (en) | Topically administered strontium-containing complexes for treating pain, pruritis and inflammation | |
US11235002B2 (en) | Strontium based compositions and formulations for pain, pruritus, and inflammation | |
CA2334843A1 (fr) | Composes diarylselenures et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetologie | |
US8975298B2 (en) | Therapeutic agent for pain | |
CA2474703A1 (en) | Therapeutic agent of glaucoma comprising bunazosin and prostaglandins | |
EP3284462A1 (en) | Strontium based compositions and formulations for pain, pruritus, and inflammation | |
US20050042241A1 (en) | Dr. Bob's Arthritis Cream | |
JPS6322518A (ja) | N−(2,6−ジクロル−m−トリル)アントラニル酸含有のゲル状製薬組成物 | |
FR2860720A1 (fr) | Nouvelles compositions pharmaceutiques pour traiter la xerostomie et maladies similaires | |
JP2019501221A (ja) | 末梢関節、脊椎関節および/または結合組織の細胞外マトリックス構成要素の処置のための製剤、製造方法および使用 | |
UA119715U (uk) | Гель "апісан" для місцевої профілактики та лікування травматичних уражень слизової оболонки порожнини рота | |
TH4847A3 (th) | สารผสมทางเภสัชกรรมสำหรับบำบัดอาการปวด | |
TH4847C3 (th) | สารผสมทางเภสัชกรรมสำหรับบำบัดอาการปวด | |
WO2013167959A1 (en) | Myrrh based composition for otological use |